4 | SEC Filings Hub

Filing metadata

Accession number: 0001470831-26-000260
Form type: Form 4
Filer: BridgeBio Pharma, Inc.
CIK: CIK 1743881
Filed: Mar 12, 2026
Reporting period: Mar 10, 2026
Description: Insider transaction

Documents

0001470831-26-000260-index.htm

Complete submission

0001470831-26-000260.txt

directory listing

Filed by

BridgeBio Pharma, Inc.